Skip to content

Author

C. de las Cuevas

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Integrating pharmacovigilance, pharmacokinetics and clinical outcomes in clozapine safety science.

Clozapine remains the most effective treatment for treatment-resistant schizophrenia, yet its use is constrained by concerns about safety and preventable adverse outcomes. Evidence on clozapine safety remains fragmented and methodologically heterogeneous, limiting translation into clinical practice. Pharmacovigilance,...

C. de las Cuevas · 0 citations
Review Open access Oct 2026

Emotional Blunting During Antidepressant Treatment: Implications for Clinical Decision‐Making and Patient‐Centred Care

ABSTRACT Rationale Emotional blunting is frequently reported during antidepressant treatment but remains conceptually underdefined. Reduced emotional reactivity and affective intensity may represent therapeutic benefit, an adverse effect, residual depressive symptomatology, or a context‐dependent combination of these p...

C. de las Cuevas · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.